1

Dr. Alexander Asam

Alexander Asam

Investment Professional - Investment Advisor Private Equity

More than 20 years of experience in the life sciences and private equity businesses. Former managing director and partner of Deutsche Venture Capital (DVC) / Deutsche Bank. Various positions at Hoechst AG, Aventis S.A. (now: Sanofi) and LION Bioscience AG, among others member of the IPO Core Team (dual listing Germany and USA). MBA degree from ASTON Business School, Birmingham and a MSc and PhD in chemistry from University of Heidelberg. Board member of APR Applied Pharma Research, ATI Autonomic Technologies, MIKA Pharma, Sublimity Therapeutics. Board observer at Corvidia Therapeutics and Vitaeris.

 

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171